The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up-Reference-Cited by-同舟云学术

The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up

Published:2010-12-23 Issue:2 Volume:12 Page:65-77
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:

Author:

Carsenti-Dellamonica H,Saïdi H,Ticchioni M,Guillouet de Salvador F,Dufayard Cottalorda J,Garraffo R,Dellamonica P,Durant J,Gougeon M-L

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2010.00848.x/fullpdf

Reference47 articles.

1. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir;Kelleher;J Infect Dis,1996

2. HIV entry inhibitors;Este;Lancet,2007

3. Enfuvirtide, a new drug for HIV infection;Fletcher;Lancet,2003

4. Enfuvirtide;Matthews;the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes,2004

5. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia;Lazzarin;N Engl J Med,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review;HIV Medicine;2019-04-22

2. CD38 Expression in a Subset of Memory T Cells Is Independent of Cell Cycling as a Correlate of HIV Disease Progression;Disease Markers;2016

3. Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case–Cohort Study;JAIDS Journal of Acquired Immune Deficiency Syndromes;2015-10-01

4. Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus ReactivationIn Vitro;Antimicrobial Agents and Chemotherapy;2014-01-13

5. Plasma Interferon-Gamma–Inducible Protein 10 Can Be Used to Predict Viral Load in HIV-1–Infected Individuals;JAIDS Journal of Acquired Immune Deficiency Syndromes;2013-07-01